tiprankstipranks
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Similar Stocks

Compare
218 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$36.81
$2.42B
-4.81%
7 Buy
3 Hold
0 Sell
Moderate Buy
Bluebird Bio
$4.08
$68.44M
-81.28%
1 Buy
4 Hold
0 Sell
Hold
Ultragenyx Pharmaceutical
$42.59
$4.11B
-12.87%
15 Buy
1 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$12.17
$1.25B
-54.72%
11 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$47.91
$4.33B
-44.41%
12 Buy
8 Hold
1 Sell
Moderate Buy
Arvinas Holding Company
$17.77
$1.26B
-62.75%
16 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
KYMR
Kymera Therapeutics
36.81
-3.68
-9.09%
BLUE
Bluebird Bio
4.08
-19.52
-82.71%
RARE
Ultragenyx Pharmaceutical
42.59
-6.29
-12.87%
NTLA
Intellia Therapeutics
12.17
-15.01
-55.22%
CRSP
Crispr Therapeutics AG
47.91
-38.28
-44.41%
ARVN
Arvinas Holding Company
17.77
-28.74
-61.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis